|
US20030133955A1
(en)
*
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US20070117863A1
(en)
*
|
1993-02-22 |
2007-05-24 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US8137684B2
(en)
|
1996-10-01 |
2012-03-20 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20030199425A1
(en)
*
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
|
PT1023050E
(pt)
*
|
1997-06-27 |
2013-12-04 |
Abraxis Bioscience Llc |
Novas formulações de agentes farmacológicos, métodos para a sua preparação e métodos para a sua utilização
|
|
US8853260B2
(en)
*
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
EP1585548B1
(en)
|
2002-12-09 |
2018-06-27 |
Abraxis BioScience, LLC |
Compositions and methods of delivery of pharmacological agents
|
|
US8735394B2
(en)
*
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
ES2678448T3
(es)
|
2005-02-18 |
2018-08-10 |
Abraxis Bioscience, Llc |
Combinaciones y modos de administración de agentes terapéuticos y terapia combinada
|
|
TWI417114B
(zh)
|
2005-08-31 |
2013-12-01 |
Abraxis Bioscience Llc |
具有增強穩定性之弱水溶性藥物之組合物及其製備方法
|
|
JP5368093B2
(ja)
*
|
2005-08-31 |
2013-12-18 |
アブラクシス バイオサイエンス， エルエルシー |
増大した安定性を有する難水溶性薬剤の組成物および調製の方法
|
|
EP2041283B1
(en)
*
|
2006-06-26 |
2013-02-20 |
The University Of British Columbia |
Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers
|
|
US20080280987A1
(en)
*
|
2006-08-31 |
2008-11-13 |
Desai Neil P |
Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
|
|
KR20090095571A
(ko)
*
|
2006-11-01 |
2009-09-09 |
조지 매이슨 인털렉춸 프로퍼티즈, 인코퍼레이티드 |
암을 검출하고 조절하기 위한 방법
|
|
CA2672618C
(en)
|
2006-12-14 |
2021-03-02 |
Abraxis Bioscience, Llc |
Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
|
|
KR20090118999A
(ko)
*
|
2007-03-07 |
2009-11-18 |
아브락시스 바이오사이언스, 엘엘씨 |
항암제로서 라파마이신 및 알부민을 포함하는 나노입자
|
|
EP3326630A3
(en)
*
|
2007-05-03 |
2018-08-29 |
Abraxis BioScience, LLC |
Methods and compositions for treating pulmonary hypertension
|
|
DK2155188T3
(da)
*
|
2007-06-01 |
2013-11-04 |
Abraxis Bioscience Llc |
Fremgangsmåder og sammensætninger til behandling af tilbagevendende kræft
|
|
MX2009013663A
(es)
*
|
2007-06-22 |
2010-01-27 |
Scidose Llc |
Formulacion solubilizada de docetaxel sin tween 80.
|
|
ITMI20080284A1
(it)
*
|
2008-02-22 |
2009-08-23 |
Indena Spa |
Agenti antitumorali a struttura benzofenantridinica e formulazioni che li contengono
|
|
CA2721153C
(en)
*
|
2008-04-10 |
2018-10-02 |
Abraxis Bioscience, Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
|
EP3266453A1
(en)
|
2008-07-03 |
2018-01-10 |
Mayo Foundation for Medical Education and Research |
Treating cancer
|
|
EP2153821A1
(en)
*
|
2008-08-06 |
2010-02-17 |
BioAlliance Pharma |
Oral formulations of camptothecin derivatives
|
|
SG172997A1
(en)
*
|
2009-01-16 |
2011-08-29 |
Rigel Pharmaceuticals Inc |
Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
|
|
AU2010224012B2
(en)
|
2009-03-13 |
2016-04-28 |
Abraxis Bioscience, Llc |
Combination therapy with thiocolchicine derivatives
|
|
CN102460167B
(zh)
|
2009-04-15 |
2015-07-22 |
阿布拉科斯生物科学有限公司 |
不含朊病毒的纳米颗粒组合物和方法
|
|
CN102573853A
(zh)
*
|
2009-07-07 |
2012-07-11 |
诺尔姆奥克西斯公司 |
使用肌醇三焦磷酸减少多药抗性的方法
|
|
US8541465B2
(en)
*
|
2009-10-19 |
2013-09-24 |
Scidose, Llc |
Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
|
|
US20110092579A1
(en)
*
|
2009-10-19 |
2011-04-21 |
Scidose Llc |
Solubilized formulation of docetaxel
|
|
US7772274B1
(en)
|
2009-10-19 |
2010-08-10 |
Scidose, Llc |
Docetaxel formulations with lipoic acid
|
|
US8912228B2
(en)
|
2009-10-19 |
2014-12-16 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
|
MA34059B1
(fr)
*
|
2010-02-23 |
2013-03-05 |
Genentech Inc |
Thérapie anti-angiogénique pour le traitement du cancer des ovaires
|
|
ES2580135T3
(es)
*
|
2010-03-26 |
2016-08-19 |
Abraxis Bioscience, Llc |
Métodos de tratamiento de carcinoma hepatocelular
|
|
AU2011232862B2
(en)
|
2010-03-29 |
2016-03-03 |
Abraxis Bioscience, Llc |
Methods of enhancing drug delivery and effectiveness of therapeutic agents
|
|
NZ628423A
(en)
|
2010-03-29 |
2016-03-31 |
Abraxis Bioscience Llc |
Methods of treating cancer
|
|
RU2576609C2
(ru)
|
2010-06-04 |
2016-03-10 |
АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи |
Способы лечение рака поджелудочной железы
|
|
KR101850566B1
(ko)
|
2010-06-07 |
2018-04-19 |
아브락시스 바이오사이언스, 엘엘씨 |
증식성 질환의 치료를 위한 조합 치료 방법
|
|
US20120121510A1
(en)
*
|
2010-11-11 |
2012-05-17 |
Brem Rachel F |
Localized therapy following breast cancer surgery
|
|
US20130323265A1
(en)
*
|
2010-11-15 |
2013-12-05 |
Oncomed Pharmaceuticals, Inc. |
Methods for treating cancer with dll4 antagonists
|
|
PT2707030T
(pt)
|
2011-05-09 |
2020-05-22 |
Mayo Found Medical Education & Res |
Tratamentos de cancro
|
|
JP6162709B2
(ja)
|
2011-11-01 |
2017-07-12 |
セルジーン コーポレイション |
シチジンアナログの経口製剤を使用して癌を治療する方法
|
|
WO2013085902A1
(en)
|
2011-12-05 |
2013-06-13 |
The University Of Texas M.D. |
Combination therapy methods for treating an inflammatory breast cancer
|
|
DK2790675T3
(da)
|
2011-12-14 |
2019-09-09 |
Abraxis Bioscience Llc |
Anvendelse af polymerexcipienser til frysetørring eller frysning af partikler
|
|
EP3553083A1
(en)
*
|
2012-03-13 |
2019-10-16 |
F. Hoffmann-La Roche AG |
Combination therapy for the treatment of ovarian cancer
|
|
US10413606B2
(en)
|
2012-10-01 |
2019-09-17 |
Mayo Foundation For Medical Education And Research |
Methods for treating cancer with nanoparticle complexes of albumin-bound paclitaxel and anti-VEGF antibodies
|
|
US9149455B2
(en)
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
|
US9511046B2
(en)
|
2013-01-11 |
2016-12-06 |
Abraxis Bioscience, Llc |
Methods of treating pancreatic cancer
|
|
CN109200031A
(zh)
*
|
2013-02-11 |
2019-01-15 |
阿布拉科斯生物科学有限公司 |
治疗黑素瘤的方法
|
|
NZ630392A
(en)
|
2013-03-12 |
2016-10-28 |
Abraxis Bioscience Llc |
Methods of treating lung cancer
|
|
RU2015143490A
(ru)
|
2013-03-14 |
2017-04-26 |
АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи |
Способы лечения рака мочевого пузыря
|
|
US10842969B2
(en)
|
2013-10-25 |
2020-11-24 |
Mercator Medsystems, Inc. |
Systems and methods of treating malacia by local delivery of hydrogel to augment tissue
|
|
WO2015134543A1
(en)
*
|
2014-03-05 |
2015-09-11 |
Sorrento Therapeutics, Inc. |
Pharmacokinetically equivalent nanoparticle compositions
|
|
EP2924022A1
(en)
*
|
2014-03-27 |
2015-09-30 |
INDENA S.p.A. |
Amorphous form of a thiocolchicine derivative
|
|
JP6695286B2
(ja)
|
2014-06-13 |
2020-05-20 |
メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ |
リンパ腫の処置
|
|
KR20170020371A
(ko)
|
2014-06-16 |
2017-02-22 |
메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 |
골수종의 치료
|
|
WO2015195634A1
(en)
|
2014-06-17 |
2015-12-23 |
Celgne Corporation |
Methods for treating epstein-barr virus (ebv) associated cancers using oral formulations of 5-azacytidine
|
|
WO2015018380A2
(en)
*
|
2014-07-03 |
2015-02-12 |
Cspc Zhongqi Pharmaceutical Technology(Shijiazhuang)Co., Ltd. |
Therapeutic nanoparticles and the preparation methods thereof
|
|
US9446148B2
(en)
|
2014-10-06 |
2016-09-20 |
Mayo Foundation For Medical Education And Research |
Carrier-antibody compositions and methods of making and using the same
|
|
PE20170242A1
(es)
*
|
2014-10-06 |
2017-03-30 |
Mayo Foundation |
Composiciones de portador-anticuerpo y metodos para realizarlas y utilizarlas
|
|
US10527604B1
(en)
|
2015-03-05 |
2020-01-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
|
|
US10705070B1
(en)
|
2015-03-05 |
2020-07-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
|
|
HUE070408T2
(hu)
|
2015-06-29 |
2025-06-28 |
Abraxis Bioscience Llc |
Szirolimuszt és albumint tartalmazó nanorészecskék epitelioid sejtes tumorok kezelésében történõ alkalmazásra
|
|
CN114796130B
(zh)
*
|
2015-08-18 |
2023-10-20 |
梅约医学教育与研究基金会 |
载体结合剂组合物及其制备和使用方法
|
|
TW201707725A
(zh)
|
2015-08-18 |
2017-03-01 |
美國馬友醫藥教育研究基金會 |
載體－抗體組合物及其製造及使用方法
|
|
WO2017176265A1
(en)
*
|
2016-04-06 |
2017-10-12 |
Mayo Foundation For Medical Education And Research |
Carrier-binding agent compositions and methods of making and using the same
|
|
TW201713360A
(en)
|
2015-10-06 |
2017-04-16 |
Mayo Foundation |
Methods of treating cancer using compositions of antibodies and carrier proteins
|
|
CN105288639A
(zh)
*
|
2015-11-23 |
2016-02-03 |
中国药科大学 |
一种载阿霉素的主动靶向白蛋白纳米载体的制备及其应用
|
|
WO2017120501A1
(en)
|
2016-01-07 |
2017-07-13 |
Mayo Foundation For Medical Education And Research |
Methods of treating cancer with interferon
|
|
CA3014531A1
(en)
|
2016-02-12 |
2017-08-17 |
Mayo Foundation For Medical Education And Research |
Hematologic cancer treatments
|
|
EP3432926A4
(en)
*
|
2016-03-21 |
2019-11-20 |
Mayo Foundation for Medical Education and Research |
METHOD FOR REDUCING THE TOXICITY OF CHEMOTHERAPEUTICS
|
|
WO2017165439A1
(en)
*
|
2016-03-21 |
2017-09-28 |
Mayo Foundation For Medical Education And Research |
Methods for improving the therapeutic index for a chemotherapeutic drug
|
|
US10618969B2
(en)
|
2016-04-06 |
2020-04-14 |
Mayo Foundation For Medical Education And Research |
Carrier-binding agent compositions and methods of making and using the same
|
|
JP7158372B2
(ja)
*
|
2016-08-05 |
2022-10-21 |
マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ |
癌治療のための修飾抗体－アルブミンナノ粒子複合体
|
|
CN110461311A
(zh)
*
|
2016-08-26 |
2019-11-15 |
奥野哲治 |
微细纳米化药剂及其应用
|
|
AU2017321798B2
(en)
|
2016-09-01 |
2023-06-15 |
Mayo Foundation For Medical Education And Research |
Methods and compositions for targeting T-cell cancers
|
|
MX2019002474A
(es)
|
2016-09-01 |
2019-09-18 |
Mayo Found Medical Education & Res |
Composiciones de agente de unión de portador-ligando-1 de muerte programada y métodos de uso de las mismas para el tratamiento de cánceres.
|
|
RU2756892C2
(ru)
|
2016-09-06 |
2021-10-06 |
Мэйо Фаундейшн Фор Медикал Эдьюкейшн Энд Рисерч |
Композиции с паклитакселом, альбумином и связывающим средством и способы их применения и получения
|
|
WO2018048816A1
(en)
|
2016-09-06 |
2018-03-15 |
Mayo Foundation For Medical Education And Research |
Methods of treating pd-l1 expressing cancer
|
|
EP3509635A1
(en)
|
2016-09-06 |
2019-07-17 |
Vavotar Life Sciences LLC |
Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins
|
|
CN106310291A
(zh)
*
|
2016-09-14 |
2017-01-11 |
东南大学 |
主动靶向抗肿瘤纳米药物及其制备方法和应用
|
|
KR102528406B1
(ko)
|
2016-10-27 |
2023-05-03 |
셀젠 콴티셀 리서치, 인크. |
브로모도메인 및 엑스트라-말단 단백질 억제제 병용 치료요법
|
|
WO2018081652A2
(en)
*
|
2016-10-28 |
2018-05-03 |
Nant Holdings Ip, Llc |
Avatar dendritic cells: the neoantigen natural killer t-cell chemo immuno radiation composition inducing immunogenic cell death
|
|
TWI838350B
(zh)
|
2017-11-06 |
2024-04-11 |
美商瑞佩特治療公司 |
抗癌劑
|
|
US20200390717A1
(en)
*
|
2017-11-21 |
2020-12-17 |
University Of Iowa Research Foundation |
Synthetically lethal nanoparticles for treatment of cancers
|
|
JP2021506839A
(ja)
*
|
2017-12-19 |
2021-02-22 |
アブラクシス バイオサイエンス， エルエルシー |
ナノ粒子ｍＴＯＲ阻害剤併用治療を使用して結腸がんを処置する方法
|
|
IL310376B1
(en)
|
2018-01-26 |
2025-10-01 |
Univ California |
Methods and compositions for treating angiogenic disorders using anti-VEGF factors
|
|
WO2019183146A1
(en)
|
2018-03-20 |
2019-09-26 |
Abraxis Bioscience, Llc |
Methods of treating central nervous system disorders via administration of nanoparticles of an mtor inhibitor and an albumin
|
|
JP2022553426A
(ja)
|
2019-10-28 |
2022-12-22 |
アブラクシス バイオサイエンス， エルエルシー |
アルブミンおよびラパマイシンの医薬組成物
|
|
CA3168512A1
(en)
|
2019-11-25 |
2021-06-03 |
Napoleone Ferrara |
Long-acting vegf inhibitors for intraocular neovascularization
|
|
KR102263606B1
(ko)
|
2020-02-11 |
2021-06-10 |
충북대학교 산학협력단 |
파클리탁셀과 알피늄이소플라본을 함유한 나노 마이셀, 이의 제조방법 및 이의 용도
|